Valuation KPC Pharmaceuticals,Inc.

Stocks

End-of-day quote Shanghai S.E. 2026-10-30			5-day change	1st Jan Change
8.670 ^CNY	+1.40%		-0.34%	-30.97%

10-23	KPC Pharmaceuticals,Inc. Reports Earnings Results for the Nine Months Ended September 30, 2026	CI
08-21	KPC Pharmaceuticals,Inc. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	8,379	10,707	15,812	11,998	9,508	6,472	-	-
Change	-	27.78%	47.68%	-24.12%	-20.76%	-31.93%	-	-
Enterprise Value (EV)	8,379	10,707	15,812	11,998	9,508	6,472	6,472	6,472
Change	-	27.78%	47.68%	-24.12%	-20.76%	-31.93%	0%	0%
P/E	16.5x	27.7x	35.4x	18.4x	27.3x	197x	25.7x	18.5x
PBR	1.75x	2.15x	2.98x	2.28x	1.77x	1.26x	1.22x	1.19x
PEG	-	-1.2x	2.3x	0.4x	-0.6x	-2.2x	0x	0.5x
Capitalization / Revenue	1.02x	1.29x	2.05x	1.43x	1.45x	1.24x	1.12x	1.01x
EV / Revenue	0x	0x	0x	0x	0x	1.24x	1.12x	1.01x
EV / EBITDA	0x	0x	0x	0x	0x	68.1x	19.7x	15.4x
EV / EBIT	0x	0x	0x	0x	0x	126x	20x	14x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	0.2	0.3	0.18	-	-	-
Rate of return	-	-	0.96%	1.89%	1.43%	-	-	-
EPS ²	0.6695	0.51	0.59	0.86	0.46	0.0433	0.3333	0.4633
Distribution rate	-	-	33.9%	34.9%	39.1%	-	-	-
Net sales ¹	8,254	8,282	7,703	8,401	6,577	5,238	5,767	6,431
EBITDA ¹	806.8	713.2	749.2	1,112	623.3	95	328	420
EBIT ¹	634	497.1	568.5	927.5	448.5	51.28	324.4	463.2
Net income ¹	507.7	383.2	444.7	648.1	349.9	35.27	249.8	351.9
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	11.050	14.120	20.860	15.850	12.560	8.550	8.550	8.550
Nbr of stocks (in thousands)	758,256	758,256	757,987	756,976	756,976	756,976	-	-
Announcement Date	3/18/22	3/22/23	3/21/24	2/10/25	2/6/26	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
KPC PHARMACEUTICALS,INC.	197.32x	-	-	-	971M
ELI LILLY AND COMPANY	40.35x	13.85x	30.26x	0.5%	1,224B
JOHNSON & JOHNSON	40.28x	6.76x	19.02x	1.94%	662B
ABBVIE INC.	38.08x	8.51x	17.61x	2.36%	514B
ROCHE HOLDING AG	21.65x	5.25x	13.07x	2.49%	388B
MERCK & CO., INC.	106.67x	5.95x	25.48x	2.33%	361B
NOVARTIS AG	22.86x	5.89x	14.22x	2.75%	302B
ASTRAZENECA PLC	22.82x	4.6x	13.15x	1.92%	271B
AMGEN INC.	29.23x	7.45x	13.34x	2.19%	249B
GILEAD SCIENCES, INC.	-47.64x	7.37x	28.55x	1.99%	205B
Average	47.16x	7.29x	19.41x	2.05%	417.78B
Weighted average by Cap.	36.70x	8.71x	21.55x	1.73%